Concepts in Cancer Modeling: A Brief History.
暂无分享,去创建一个
R. M. Thomas | T. Van Dyke | G. Merlino | C.-P. Day | G. Merlino | T. van Dyke | Chi-Ping Day | Renee M Thomas
[1] Stuart K. Kim,et al. The early bird catches the worm: new technologies for the Caenorhabditis elegans toolkit , 2011, Nature Reviews Genetics.
[2] H. Skipper,et al. The effects of chemotherapy on the kinetics of leukemic cell behavior. , 1965, Cancer research.
[3] R. Shoemaker. The NCI60 human tumour cell line anticancer drug screen , 2006, Nature Reviews Cancer.
[4] Jason B. Williams,et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy , 2015, Science.
[5] S Perry,et al. Kinetics of normal and leukemic leukocyte populations and relevance to chemotherapy. , 1970, Cancer research.
[6] Berenbaum Mc,et al. In vivo determination of the fractional kill of human tumor cells by chemotherapeutic agents. , 1972 .
[7] Edward Chu,et al. A history of cancer chemotherapy. , 2008, Cancer research.
[8] I. Fidler,et al. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.
[9] J. Wilmott,et al. Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma , 2011, Clinical Cancer Research.
[10] I. Fidler,et al. Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. , 1980, Cancer research.
[11] Ruchir R. Shah,et al. Abstract 3928: Inhibition of the ubiquitin proteasome system differentially regulates glucocorticoid receptor-mediated transcriptional processes , 2012 .
[12] Y. Lazebnik. Can a biologist fix a radio? — or, what I learned while studying apoptosis , 2004, Biochemistry (Moscow).
[13] S Paget,et al. THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .
[14] Katsusaburo Yamagiwa,et al. Experimental Study of the Pathogenesis of Carcinoma , 1918 .
[15] K. Mäler,et al. Modeling Complex Ecological Economic Systems: Toward an Evolutionary, Dynamic Understanding of People and Nature , 1993 .
[16] H. Skipper,et al. EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA. , 1964, Cancer chemotherapy reports.
[17] R. Hertz,et al. Therapy of choriocarcinoma and related trophoblastic tumors with folic acid and purine antagonists. , 1958, The New England journal of medicine.
[18] M C Berenbaum,et al. In vivo determination of the fractional kill of human tumor cells by chemotherapeutic agents. , 1972, Cancer chemotherapy reports.
[19] T. Graeber,et al. BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapy. , 2012, Cancer research.
[20] I. Fidler,et al. Metastasis results from preexisting variant cells within a malignant tumor. , 1977, Science.
[21] C. Bucana,et al. Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin. , 1981, Journal of the National Cancer Institute.
[22] A. Ribas,et al. Combining targeted therapy with immunotherapy in BRAF-mutant melanoma: promise and challenges. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] T. Gajewski,et al. Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity , 2015, Nature.
[24] H. Richardson,et al. Using Drosophila melanogaster to map human cancer pathways , 2005, Nature Reviews Cancer.
[25] K Yamagiwa,et al. Experimental study of the pathogenesis of carcinoma , 1977, CA: a cancer journal for clinicians.
[26] J. R. Brown,et al. Percivall Pott (1714-1788) and Chimney Sweepers' Cancer of the Scrotum , 1957, British journal of industrial medicine.
[27] R. L. Costanz,et al. Modeling complex ecological economic systems , 1993 .
[28] L. Steinmetz,et al. Yeast as a system for modeling mitochondrial disease mechanisms and discovering therapies , 2015, Disease Models & Mechanisms.
[29] S. Lippman,et al. Cancer prevention: from 1727 to milestones of the past 100 years. , 2009, Cancer research.